You are here: Home » PTI Stories » National » News
Business Standard

Sanofi Pasteur launches injectable inactivated polio vaccine

Press Trust of India  |  Hyderabad 

Sanofi Pasteur, the vaccines division of Sanofi, today announced launch of ShanIPV, an injectable inactivated polio vaccine (IPV).

Telangana Chief Minister K Chandrasekhar Rao launched the vaccine here, a company release said.

ShanIPV would be manufactured by Sanofi Pasteur's affiliate Shantha Biotechnics in Hyderabad. ShanIPV is a trivalent inactivated, injectable polio vaccine.

Sanofi Pasteur and Shantha would provide majority of vaccine doses needed for the introduction by the end of 2016. All vaccines (both Imovax Polio of Sanofi Pasteur and ShanIPV of Shantha) would be delivered in India through UNICEF.

"With the introduction of IPV in the immunisation schedule, our Company is playing a key role in achieving the goal of a polio-free world," said Shailesh Ayyangar, Managing Director - India and Vice President - South Asia, Sanofi.

"Towards the polio eradication programme, we will manufacture massive quantities of high-quality, safe and efficacious IPV vaccines to meet all the milestones in the timeline set by the Indian Government," Mahesh Bhalgat, Executive Director and Chief Operating Officer, Shantha Biotechnics, said.

"In line with the WHO's Global endgame strategy, India is introducing one dose of IPV at 14 weeks of age. IPV is to be given in addition to the existing oral polio vaccine. This introduction is a critical step towards achieving a polio-free world by 2019 to meet the Global Polio Eradication Initiative Endgame Strategic Plan," the company said in the release.

India was declared a polio-free nation in 2014.

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Fri, December 04 2015. 19:28 IST